查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1848564

心臟瓣膜修復和置换设备市场：2025-2032 年全球预测（按置换和修復设备）

Heart Valve Repair & Replacement Devices Market by Replacement Devices, Repair Devices - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，心臟瓣膜修復和置换设备市场将成长至 127 亿美元，复合年增长率为 8.44%。

主要市场统计数据
基准年2024年 66.4亿美元
预计2025年 72亿美元
预测年份：2032年 127亿美元
复合年增长率（%） 8.44%

全面介绍影响心臟瓣膜修復和置换术的不断发展的临床、技术和商业性动态

心臟瓣膜修復与置换术领域正处于外科传统与快速导管创新交会的关键曲折点。影像学、器械设计和围手术全期管理方面的进步正在逐步改变临床决策路径，并为不同频谱的患者提供更广泛的治疗选择。这项发展反映了心血管治疗领域的更广泛变化，包括多学科心臟团队、更完善的患者选择标准，以及对瓣膜长期表现和生活品质的重视。

如今，临床医生和医疗保健系统不仅会评估瓣膜介入治疗的急性手术成功率，还会考虑其耐久性、再次介入的必要性以及对未来经导管治疗的影响。因此，技术开发商和器材製造商优先考虑模组化、易于部署以及与瓣中瓣策略的兼容性。同时，监管机构和支付方也越来越关注真实世界证据和比较有效性，从而决定了瓣膜介入治疗的商业化和报销路径。

综合起来，这些因素共同构成了一个动态格局，临床需求、技术能力和商业性需求相互作用。相关人员若能理解这些动态，并协调其产品开发、临床证据产生和打入市场策略，将最有能力影响治疗途径，并抓住治疗模式转变带来的机会。

临床创新、诊断影像的进步以及实证商业化如何改变心臟瓣膜的治疗方式和途径

过去几年发生了一场革命性的转变，彻底改变了临床医师治疗心臟瓣膜疾病的方式。微创经导管技术已从一种小众选择发展成为针对特定患者群体的主流治疗方法，这得益于输送系统、密封机制和器械外形的改进，这些改进减少了手术创伤并缩短了恢復时间。同时，血管假体的改进，包括组织处理和血流动力学优化，也持续改善了年轻、活跃患者的治疗效果。

科技的融合正在加速进步。增强型显像模式、计算建模和术中引导系统如今能够实现精准的计画和操作，从而减少治疗结果的差异性。这些工具增强了治疗复杂解剖结构的信心，并扩大了适合微创治疗的患者群体。此外，对瓣膜耐久性和再干预途径管理的日益重视，也加强了开发支持分阶段治疗（包括瓣中瓣和混合治疗）的设备平台的力度。

在商业性方面，设备创新者与成熟临床网路之间的策略伙伴关係正在加速新技术的实用化。循证生成策略也在不断发展，涵盖了稳健的註册和现场试验，以记录其在常规护理中的长期表现。总而言之，这些转变正在创造一个更具竞争力、以证据主导的环境，其成功取决于能否证明临床价值、简化应用流程并确保患者的长期效益。

评估近期关税变化将如何重塑整个心臟瓣膜设备生态系统的供应链、采购行为和策略製造决策

关税状况为整个心臟瓣膜设备生态系统的供应链设计、筹资策略和价格谈判带来了新的变数。关税调整将影响进口零件和组装设备的成本结构，促使製造商重新评估筹资策略，并考虑近岸外包、供应商多元化和垂直整合，以降低风险。这些应对措施将影响前置作业时间、库存持有成本以及与医疗保健采购商的合约承诺。

临床医生的需求和医院的采购週期会对总拥有成本的细微变化做出反应，尤其是在关税引发的价格波动影响大批量生产中心常规使用的设备时。医院和医疗系统可能会加强对采购决策的审查，要求更清晰的价值提案，并优先考虑能够展现供应弹性和透明定价的供应商。同时，监管提交和竞标流程可能需要更新成本效益文件，以反映投入成本的变化。

除了即时的采购效应外，关税还可能加速供应商之间的策略整合，并引发生产能力的地理重新分配。对于新参与企业而言，关税波动提升了生产弹性和本地临床伙伴关係关係的策略重要性，从而支持其市场准入。同时，拥有多元化生产基地的现有企业可以利用其不断扩大的规模和完善的物流系统来保持竞争优势。整体而言，关税动态增加了营运的复杂性，需要积极主动的情境规划和敏捷的商业执行。

详细的細項分析揭示了手术和经导管设备路径、组织采购和修復方式如何定义临床和商业性差异

对心臟瓣膜市场进行细分，可以揭示影响产品开发和商业化策略的不同技术路径和临床决策树。就替代疗法而言，市场分为外科手术和经导管两种方法。外科手术瓣膜置换术术根据机械瓣膜和组织瓣膜的选择而有所不同，组织瓣膜又进一步细分为同种异体移植瓣膜、支架瓣膜和非支架瓣膜。经导管人工瓣膜置换术透过专用输送系统和解剖标靶引入了另一个细分维度，涵盖经导管主动脉瓣置换术、经导管二尖瓣置换术和经导管肺动脉瓣置换术。

修復疗法并行运作，但有类似的细微差别。外科修復包括瓣环状成形术、腱索置换装置和瓣膜再形成技术。瓣环状成形术环依其柔韧性分为柔性、刚性和半刚性设计，腱索置换环状成形术则包括自体心包重组和合成腱索置换。经导管修復领域已出现不同的系统类别，例如瓣环成形系统和瓣叶对合技术，例如夹子和瓣叶置换装置。在环状成形术系统中，商业性主流的方法包括经皮、解剖匹配的带环和环圈解决方案。

了解这些细分路径有助于明确临床价值提案、监管证据需求和製造影响。例如，组织采购和加工会影响手术结构的耐久性，而输送导管的设计和固定策略则决定了经导管平台的开发重点。同样，修復和置换之间的差异会影响移植中心的报销定位和培训需求。因此，具备细分感知能力的策略能够使开发人员和商业团队将研发投资与手术实际情况和付款人的期望相协调。

区域采用模式和存取动态将决定监管机构、付款人和临床基础设施如何影响心臟瓣膜设备在全球市场上的商业化。

地理动态在心臟瓣膜技术的采用模式、监管途径和商业模式中发挥着至关重要的作用。美洲地区拥有先进的介入基础设施和强劲的临床试验活动，支援微创技术的快速应用和强大的上市后资料收集。欧洲、中东和非洲 (EMEA) 地区的监管和报销格局各不相同，快速应用的市场与依赖集中采购和医院预算限制的市场并存。

亚太地区的医疗保健体系成熟度参差不齐，一些市场在患者群体庞大和三级医疗能力提升的推动下，正快速普及。本地製造以及与区域临床网路的合作正在加速一些亚太国家的医疗技术进入，而监管协调和基础设施建设仍然是其他地区的重点。在整个地区，技能水平、临床医生培训途径以及公立和私人医疗服务模式的差异正在影响技术的采用和扩展方式。

区域洞察凸显，一刀切的商业性模式无法带来成效。成功的市场策略应预测当地监管要求，使临床证据方案与当地付款人的期望一致，并根据移植中心的营运实际情况量身定制培训和服务模式。跨境伙伴关係、本地临床领导者以及灵活的交付模式是将创新转化为持续在地应用的关键。

竞争与合作的动态，结合成熟的外科专业知识、敏捷的创新与策略伙伴关係，塑造市场领导地位

心臟瓣膜领域的竞争态势反映出既有成熟的外科手术领导企业，也有专注于经导管和修復技术的敏捷创新者。成熟的外科手术器械製造商拥有规模、监管专业知识和长期临床数据集等优势，这些优势支持其在註重耐用性和性能验证的医疗中心的应用。这些公司通常利用涵盖组织处理、人工替代物工程和全球分销网络的全面产品组合来支持临床教育和跨市场扩张。

同时，规模较小、更专注的公司正在推动颠覆性进步，他们专注于输送系统、密封技术以及扩展微创方法的解剖相容性机制。这些公司经常与学术中心合作，以产生早期临床证据，并透过迭代学习快速改进设备迭代。创新者与大型公司之间的策略联盟和授权协议正变得越来越普遍，因为双方都寻求互补的能力，例如生产规模、监管参与和上市执行。

服务和培训生态系统也是一项关键的竞争优势。提供强大的临床医生培训、模拟和监考支援的供应商，能够加速流程采用并降低结果的差异性，从而增强其商业性提案。随着采用模式的转变，那些将卓越技术与可扩展的临床医生支持和证据生成能力相结合的机构，将在临床路径领域占据持久地位。

可行的建议，整合证据产生、供应链弹性、临床医生培训和模组化技术设计，以加速采用和商业性成功

领导者应优先考虑整合策略，将临床证据产生与可扩展的商业营运和弹性供应链结合。首先，投资一个强大的真实世界证据项目，透过记录长期表现、患者报告结果以及在不同临床环境下的比较有效性，补充关键临床试验。其次，透过多元化的供应商网路和区域生产能力，追求製造和采购的灵活性，以降低关税和物流风险，同时保持品质和成本竞争力。

第三，我们将建立深入的临床伙伴关係和培训基础设施，以促进安全应用，减少程序差异，并培养能够在我们网络内清晰阐述我们设备价值的本地领导者。第四，我们将设计模组化平台和可互通的交付系统，以促进逐步护理并简化医院系统的库存管理。模组化还能增强在不中断既定流程的情况下迭代设备生命週期的能力。最后，为了满足付款人的优先事项并展示长期价值，我们将采用能够反映护理总成本的复杂定价策略，并在适当情况下支持基于结果的合约。

透过执行这些相互关联的优先事项，行业领导者可以将技术进步转化为永续的临床应用和商业性成功，同时应对不断变化的监管和付款人环境。

结合主要临床医生访谈、文献综合、设备路径映射和供应链风险评估的透明调查方法支持可行的见解

本研究结合了透过对临床医生、设备工程师、监管专家和采购负责人进行结构化访谈收集的一手资料和二手资料，并辅以同行评审的临床文献和手术登记册的分析。一手资料着重于对手术决策、设备选择标准和实施障碍的定性洞察，而二手资料则提供有关技术趋势、监管先例和不断发展的临床指南的背景资讯。调查方法优先考虑跨输入类型的三角测量，以确保主题结论的稳健性，并减轻与单一资讯来源观点相关的偏差。

分析方法包括器械路径图、临床结果三角测量和供应链风险评估。器械路径图将设计属性与程序工作流程和培训需求连结起来，而结果三角测量则将早期临床报告与註册资料进行比较，以识别一致的绩效讯号。供应链评估评估了采购强度、物流依赖性以及潜在关税对成本和前置作业时间的影响。在可能的情况下，透过与专家的后续讨论来检验研究结果，以完善解释并检验方案。

因此，相关人员可以将洞察直接应用于策略规划、产品开发优先排序和上市排序。方法的透明度支援可重复性，允许客户根据需要请求更深入地研究特定的细分市场或区域。

关于综合证据、营运弹性和策略性商业化如何定义心臟瓣膜护理的长期领导地位的最终观点

心臟瓣膜修復与置换领域正迈入更微妙的时代，器械创新、临床证据和系统层面的经济效益将共同决定哪些技术能够成功。随着经导管技术的扩展和外科人工替代物的不断发展，耐久性、再次介入途径和以患者为中心的治疗结果之间的相互作用将日益影响治疗方案的选择。能够整合严谨的证据产生、敏捷的製造和有针对性的区域策略的相关人员将最有能力影响临床实践并获得长期价值。

营运弹性和有计划的商业化方法比以往任何时候都更加重要。关税趋势和供应链的复杂性需要积极规划，而竞争差异化则取决于能否展现出与临床医生、付款人和医疗系统领导者产生共鸣的真正优势。投资于临床医生培训、可扩展服务模式和模组化设备平台的公司将降低采用门槛，并支持更广泛的应用。

最终，该领域的持续领导地位将来自于那些在科学严谨性与商业性实用性之间取得平衡的公司，他们的产品策略以可证明的患者利益为中心，同时确保后勤和经济方面的考虑支持可靠且负担得起的医疗保健服务。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 锚固型经导管二尖瓣置换系统在重度逆流患者的应用
  • 3D列印和整合的患者专用心臟瓣膜支架，实现个人化修復效果
  • 引入微创机器人辅助主动脉瓣置换术以缩短住院时间
  • 开发用于减少血栓症的下一代经导管心臟瓣膜的可吸收聚合物瓣膜
  • 透过提高即时血流动力学监测感测器的利用率来优化人工心臟瓣膜的性能
  • 扩大瓣中瓣手术适应症，适用于有功能障碍的生物瓣膜的高风险手术患者
  • 经皮三尖瓣修復装置在老年功能性三尖瓣逆流患者的应用

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 心臟瓣膜修復置换设备市场置换设备

  • 手术置换
    • 机械阀
    • 组织瓣膜
      • 同种异体移植
      • 组织瓣膜瓣膜
      • 牛
      • 猪肉瓣
      • 无支架组织瓣膜
  • 经导管置换术
    • 塔武尔
    • 汤姆·巴尔
    • 轻敲

9. 心臟瓣膜修復置换设备市场修復设备

  • 手术修復
    • 环状成形术环
      • 柔性环
      • 刚性环
      • 半刚性环
    • 和弦替换装置
      • 自体心包索
      • 合成绳
    • 瓣环成形装置
  • 经导管修復
    • 环状成形术系统
      • 有氧运动带
      • 二尖瓣环折迭术
    • 二尖瓣夹系统
    • 帕斯卡系统

10. 心臟瓣膜修復和置换设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 11 章。心臟瓣膜修復和置换设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

12. 心臟瓣膜修復和置换设备市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十三章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Edwards Lifesciences Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • LivaNova PLC
    • CryoLife, Inc.
    • Terumo Corporation
    • MicroPort Scientific Corporation
Product Code: MRR-925E8149CC89

The Heart Valve Repair & Replacement Devices Market is projected to grow by USD 12.70 billion at a CAGR of 8.44% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.64 billion
Estimated Year [2025] USD 7.20 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 8.44%

A comprehensive introduction to the evolving clinical, technological, and commercial dynamics reshaping heart valve repair and replacement pathways

The field of heart valve repair and replacement stands at a pivotal inflection point where surgical tradition intersects with rapid transcatheter innovation. Advances in imaging, device design, and perioperative management have progressively shifted clinical decision-making pathways, expanding therapeutic options for patients across risk spectra. This evolution reflects broader changes in cardiovascular care, including multidisciplinary heart teams, refined patient selection criteria, and a stronger emphasis on long-term valve performance and quality of life.

Clinicians and health systems now evaluate valve interventions not only through the lens of acute procedural success but also by durability, need for reintervention, and implications for future transcatheter access. As a result, technology developers and device manufacturers are prioritizing modularity, ease of deployment, and compatibility with valve-in-valve strategies. Concurrently, regulatory authorities and payers are increasingly focused on real-world evidence and comparative effectiveness, shaping the pathway for commercialization and reimbursement.

Taken together, these elements create a dynamic landscape in which clinical needs, technological capability, and commercial imperatives interact. Stakeholders that understand these dynamics and align product development, clinical evidence generation, and market access strategies will be best positioned to influence care pathways and capture opportunities arising from the shifting treatment paradigm.

How clinical innovation, imaging advances, and evidence-driven commercialization are collectively transforming heart valve treatment modalities and care pathways

Recent years have delivered transformative shifts that extend beyond incremental device improvements to alter how clinicians approach valve disease entirely. Minimally invasive transcatheter techniques have matured from niche options to mainstream therapies for certain patient groups, driven by improvements in delivery systems, sealing mechanisms, and device profiles that reduce procedural trauma and recovery time. At the same time, refinements in surgical prostheses, including tissue processing and hemodynamic optimization, continue to elevate performance for younger and more active patients.

Technology convergence has accelerated progress. Enhanced imaging modalities, computational modeling, and intra-procedural guidance systems now enable precision planning and device placement that reduce variability in outcomes. These tools foster higher confidence in treating complex anatomies, which expands the population eligible for less invasive approaches. Furthermore, the emphasis on valve durability and the management of reintervention pathways has intensified efforts to develop device platforms that support staged therapies, including valve-in-valve or hybrid approaches.

On the commercial front, strategic partnerships between device innovators and established clinical networks expedite the translation of new technologies into practice. Evidence generation strategies have evolved to include robust registries and pragmatic trials that capture longitudinal performance in routine care. Collectively, these shifts create a more competitive, evidence-driven environment where the ability to demonstrate clinical value, streamline adoption, and ensure long-term patient benefit determines success.

Assessing how recent tariff changes reshape supply chains, procurement behavior, and strategic manufacturing decisions across the heart valve device ecosystem

The tariff landscape has introduced new variables for supply chain design, procurement strategies, and pricing negotiations across the heart valve device ecosystem. Tariff adjustments influence cost structures for imported components and assembled devices, prompting manufacturers to reassess sourcing strategies and consider nearshoring, supplier diversification, or vertical integration to mitigate exposure. These responses have implications for lead times, inventory carrying costs, and contractual commitments with healthcare purchasers.

Clinician demand and hospital purchasing cycles respond to subtle shifts in total cost of ownership, particularly when tariff-induced price changes affect devices used routinely in high-volume centers. Hospitals and health systems may increase scrutiny of procurement decisions, demand clearer value propositions, and prioritize vendors that can demonstrate supply resilience and transparent pricing. In parallel, regulatory submissions and tender processes may require updated cost-effectiveness documentation that reflects changed input costs.

Beyond immediate procurement effects, tariffs can accelerate strategic consolidation among suppliers and trigger geographic repositioning of manufacturing capacity. For newer entrants, tariff volatility elevates the strategic importance of manufacturing flexibility and local clinical partnerships to support market entry. Meanwhile, established incumbents with diversified production footprints can leverage scale and logistics sophistication to maintain competitive advantage. Overall, tariff dynamics add a layer of operational complexity that requires proactive scenario planning and agile commercial execution.

Deep segmentation analysis revealing how surgical and transcatheter device pathways, tissue sourcing, and repair modalities define clinical and commercial differentiation

Segmenting the heart valve market illuminates distinct technology pathways and clinical decision trees that influence product development and commercialization strategies. When considering replacement therapies, the market divides into surgical and transcatheter approaches. Surgical replacement remains differentiated by mechanical and tissue valve options, with tissue valves further subdivided into homografts, stented and stentless designs; stented constructs commonly draw on bovine pericardial and porcine tissue sources. Transcatheter replacement introduces another axis of segmentation through dedicated delivery systems and anatomic targets, covering transcatheter aortic replacement, transcatheter mitral replacement, and transcatheter pulmonary replacement systems, each with unique device design constraints and clinical endpoints.

Repair therapies constitute a parallel but equally nuanced landscape. Surgical repair includes annuloplasty rings, chordal replacement devices, and valve reshaping technologies, where annuloplasty rings are themselves classified by flexibility characteristics into flexible, rigid, and semi-rigid designs, and chordal replacement options range from autologous pericardial reconstructions to synthetic chordae. The transcatheter repair domain has emerged with distinct system classes such as annuloplasty systems and leaflet approximation technologies like clip and alternative leaflet devices; within annuloplasty systems, commercially prominent approaches include band and loop-like solutions tailored to percutaneous anatomy.

Understanding these segmentation pathways clarifies clinical value propositions, regulatory evidence needs, and manufacturing implications. For example, tissue sourcing and processing impact durability narratives for surgical constructs, while delivery catheter design and anchoring strategies drive development priorities for transcatheter platforms. Similarly, the distinctions between repair and replacement inform reimbursement positioning and training requirements for implanting centers. Segment-aware strategies therefore enable developers and commercial teams to align R&D investments with procedural realities and payer expectations.

Regional adoption patterns and access dynamics that determine how regulatory, payer, and clinical infrastructures shape heart valve device commercialization across global markets

Geographic dynamics play a decisive role in adoption patterns, regulatory pathways, and commercial models for heart valve technologies. The Americas exhibit advanced interventional infrastructure and strong clinical trial activity, supporting rapid uptake of minimally invasive techniques and robust post-market data collection; payers in this region increasingly seek evidence of long-term value and comparative effectiveness when evaluating new devices. Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape where high-adoption pockets coexist with markets that depend on centralized procurement and constrained hospital budgets; pricing strategies and health technology assessment outcomes strongly influence market access timelines across this region.

Asia-Pacific demonstrates diverse maturity across national health systems, with several markets showing rapid adoption driven by large patient populations and growing capacities in tertiary centers. In some countries within Asia-Pacific, local manufacturing and partnerships with regional clinical networks accelerate entry, while in others, regulatory harmonization and infrastructure build-out remain focal areas. Across all regions, differences in procedural volumes, clinician training pathways, and public versus private healthcare delivery models shape how technologies are introduced and scaled.

Regional insights underscore that a one-size-fits-all commercial approach will underdeliver. Instead, successful market strategies anticipate local regulatory requirements, adapt clinical evidence packages to regional payer expectations, and tailor training and service models to the operational realities of implanting centers. Cross-border partnerships, local clinical champions, and flexible supply models are instrumental in translating innovation into sustained regional adoption.

Competitive and collaborative dynamics that combine established surgical prowess with nimble innovation and strategic partnerships to shape market leadership

Competitive dynamics in the heart valve space reflect a mix of long-established surgical leaders and agile innovators focused on transcatheter and repair technologies. Incumbent surgical device manufacturers maintain strengths in scale, regulatory expertise, and long-term clinical datasets that underpin adoption in centers where durability and proven performance remain primary considerations. These organizations often leverage comprehensive portfolios that span tissue processing, prosthesis engineering, and global distribution networks to support clinical education and multi-market rollouts.

At the same time, smaller and more focused companies drive disruptive progress by concentrating on delivery systems, sealing technologies, and mechanisms that expand anatomical suitability for less invasive approaches. These firms frequently collaborate with academic centers to generate early clinical evidence and refine device iterations quickly through iterative learning. Strategic alliances and licensing agreements between innovators and larger firms are common as each side seeks complementary capabilities, whether in manufacturing scale, regulatory navigation, or market access execution.

Service and training ecosystems are also pivotal competitive assets. Providers who offer robust clinician training, simulation, and proctoring support accelerate procedural adoption and reduce variability in outcomes, thereby enhancing the commercial proposition. As adoption patterns shift, organizations that combine technical excellence with scalable clinician support and evidence generation capabilities will secure durable positions in clinical pathways.

Actionable recommendations that integrate evidence generation, supply chain resilience, clinician training, and modular technology design to accelerate adoption and commercial success

Leaders should prioritize integrated strategies that align clinical evidence generation with scalable commercial operations and resilient supply chains. First, invest in robust, real-world evidence programs that complement pivotal trials by documenting long-term performance, patient-reported outcomes, and comparative effectiveness in diverse clinical settings; such evidence underpins payer dialogues and supports favorable reimbursement pathways. Second, pursue manufacturing and sourcing flexibility through diversified supplier networks and regional production capacities to mitigate tariff and logistics risks while preserving quality and cost competitiveness.

Third, cultivate deep clinical partnerships and training infrastructure to accelerate safe adoption, reduce procedural variability, and foster local champions who can articulate device value within their networks. Fourth, design modular platforms and interoperable delivery systems that facilitate staged therapies and simplify inventory management for hospital systems; modularity also enhances the ability to iterate device lifecycles without disrupting established procedural workflows. Finally, adopt sophisticated pricing strategies that reflect total cost of care implications and support outcomes-based contracting where appropriate to address payer priorities and demonstrate value over time.

By executing on these interconnected priorities, industry leaders can convert technical advances into sustainable clinical adoption and commercial success while remaining responsive to evolving regulatory and payer environments.

Transparent research methodology combining primary clinician interviews, literature synthesis, device pathway mapping, and supply chain risk assessment to support actionable insights

This research synthesizes primary and secondary evidence gathered through structured interviews with clinicians, device engineers, regulatory specialists, and procurement leaders, supplemented by analysis of peer-reviewed clinical literature and procedural registries. Primary research emphasized qualitative insights into procedural decision-making, device selection criteria, and adoption barriers, while secondary sources provided context on technological trends, regulatory precedents, and clinical guideline evolution. The methodology prioritized triangulation across input types to ensure the robustness of thematic conclusions and to reduce bias associated with single-source perspectives.

Analytical approaches included device pathway mapping, clinical outcome triangulation, and supply chain risk assessment. Device pathway mapping linked design attributes to procedural workflows and training needs, whereas outcome triangulation compared early clinical reports with registry data to identify consistent performance signals. Supply chain assessments evaluated sourcing concentration, logistics dependencies, and potential tariff impacts on cost and lead time. Wherever possible, findings were validated through follow-up discussions with domain experts to refine interpretation and test scenario plausibility.

The resulting synthesis focuses on actionable implications rather than predictive estimates, enabling stakeholders to apply insights directly to strategic planning, product development prioritization, and market entry sequencing. Transparency in methods supports reproducibility and allows clients to request deeper dives into specific segments or geographies as needed.

Concluding perspective on how integrated evidence, operational resilience, and strategic commercialization will define long-term leadership in heart valve therapies

The heart valve repair and replacement domain is transitioning to a more nuanced era where device innovation, clinical evidence, and system-level economics jointly determine which technologies succeed. As transcatheter techniques expand and surgical prostheses continue to evolve, the interplay between durability, reintervention pathways, and patient-centered outcomes will increasingly drive therapeutic choices. Stakeholders who integrate rigorous evidence generation with agile manufacturing and targeted regional strategies will be best positioned to influence clinical practice and capture long-term value.

Operational resilience and deliberate commercialization approaches matter now more than ever. Tariff dynamics and supply chain complexities require proactive planning, while competitive differentiation depends on demonstrating real-world benefits that resonate with clinicians, payers, and health system leaders. Companies that invest in clinician training, scalable service models, and modular device platforms will reduce barriers to adoption and support broader procedural diffusion.

Ultimately, sustained leadership in this space will come from organizations that balance scientific rigor with commercial pragmatism, anchoring product strategies in demonstrable patient benefit while ensuring that logistical and economic considerations support reliable, affordable access to care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Emergence of transcatheter mitral valve replacement systems with enhanced anchoring in patients with severe regurgitation
  • 5.2. Integration of 3D printed patient specific heart valve scaffolds for personalized repair outcomes
  • 5.3. Adoption of minimally invasive robotic assisted aortic valve replacement techniques to reduce hospital stays
  • 5.4. Development of resorbable polymeric leaflets for next generation transcatheter heart valves with reduced thrombosis
  • 5.5. Increased utilization of real time hemodynamic monitoring sensors in prosthetic heart valves for performance optimization
  • 5.6. Expanding indications for valve in valve procedures in high risk surgical candidates with failing bioprostheses
  • 5.7. Growth of percutaneous tricuspid valve repair devices targeting functional tricuspid regurgitation in elderly patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Repair & Replacement Devices Market, by Replacement Devices

  • 8.1. Surgical Replacement
    • 8.1.1. Mechanical Valves
    • 8.1.2. Tissue Valves
      • 8.1.2.1. Homografts
      • 8.1.2.2. Stented Tissue Valves
      • 8.1.2.2.1. Bovine Pericardial Valves
      • 8.1.2.2.2. Porcine Valves
      • 8.1.2.3. Stentless Tissue Valves
  • 8.2. Transcatheter Replacement
    • 8.2.1. Tavr
    • 8.2.2. Tmvr
    • 8.2.3. Tpvr

9. Heart Valve Repair & Replacement Devices Market, by Repair Devices

  • 9.1. Surgical Repair
    • 9.1.1. Annuloplasty Rings
      • 9.1.1.1. Flexible Rings
      • 9.1.1.2. Rigid Rings
      • 9.1.1.3. Semi-Rigid Rings
    • 9.1.2. Chordal Replacement Devices
      • 9.1.2.1. Autologous Pericardial Chordae
      • 9.1.2.2. Synthetic Chordae
    • 9.1.3. Valve Reshaping Devices
  • 9.2. Transcatheter Repair
    • 9.2.1. Annuloplasty Systems
      • 9.2.1.1. Cardioband
      • 9.2.1.2. Mitral Loop Cerclage
    • 9.2.2. Mitral Clip Systems
    • 9.2.3. PASCAL Systems

10. Heart Valve Repair & Replacement Devices Market, by Region

  • 10.1. Americas
    • 10.1.1. North America
    • 10.1.2. Latin America
  • 10.2. Europe, Middle East & Africa
    • 10.2.1. Europe
    • 10.2.2. Middle East
    • 10.2.3. Africa
  • 10.3. Asia-Pacific

11. Heart Valve Repair & Replacement Devices Market, by Group

  • 11.1. ASEAN
  • 11.2. GCC
  • 11.3. European Union
  • 11.4. BRICS
  • 11.5. G7
  • 11.6. NATO

12. Heart Valve Repair & Replacement Devices Market, by Country

  • 12.1. United States
  • 12.2. Canada
  • 12.3. Mexico
  • 12.4. Brazil
  • 12.5. United Kingdom
  • 12.6. Germany
  • 12.7. France
  • 12.8. Russia
  • 12.9. Italy
  • 12.10. Spain
  • 12.11. China
  • 12.12. India
  • 12.13. Japan
  • 12.14. Australia
  • 12.15. South Korea

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Analysis
    • 13.3.1. Edwards Lifesciences Corporation
    • 13.3.2. Medtronic plc
    • 13.3.3. Abbott Laboratories
    • 13.3.4. Boston Scientific Corporation
    • 13.3.5. LivaNova PLC
    • 13.3.6. CryoLife, Inc.
    • 13.3.7. Terumo Corporation
    • 13.3.8. MicroPort Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 7. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASEAN HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GCC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPEAN UNION HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. BRICS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. G7 HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. NATO HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOMOGRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BOVINE PERICARDIAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PORCINE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TAVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TMVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TPVR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY FLEXIBLE RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY RIGID RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SEMI-RIGID RINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AUTOLOGOUS PERICARDIAL CHORDAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SYNTHETIC CHORDAE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE RESHAPING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIOBAND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL LOOP CERCLAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL CLIP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PASCAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED TISSUE VALVES, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPLACEMENT, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL REPAIR, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPLACEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER REPAIR, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY